Collecting Duct Carcinoma

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study [Phase 2]

  Phase 2 trial exploring the addition of radium-223 dichloride to cabozantinib for advanced renal cell carcinoma with bone metastases (RadiCa…

• CLINICAL_TRIALS research · 2025-09-09
  Clinical Trial Update: Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma [Phase 2]

  A Phase 2 trial is evaluating pembrolizumab plus enfortumab vedotin for collecting duct carcinoma and renal medullary carcinoma, currently r…

• CLINICAL_TRIALS research · 2024-11-26
  Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma [Phase 2]

  Phase 2 trial evaluating immunotherapy in combination with Axitinib for advanced collecting duct carcinoma is currently recruiting.

• CLINICAL_TRIALS trial_result · 2021-05-10
  Clinical Trial Update: caBozantinib in cOllectiNg ductS Renal Cell cArcInoma [Phase 2]

  Phase 2 trial of caBozantinib in collecting duct carcinoma of the kidney completed.

• CLINICAL_TRIALS trial_result · 2021-03-09
  Clinical Trial Update: Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24) [Phase 2]

  Phase 2 trial evaluating gemcitabine plus platinum salt plus bevacizumab for metastatic collecting duct carcinoma of the kidney has complete…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-04-08
  Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer [Phase 2]

  Phase 2 trial results for Pazopanib hydrochloride in metastatic or recurrent kidney cancers have been posted after the study completed, incl…